Henry Schein (HSIC) Reports Next Week: Wall Street Expects Earnings Growth
Are Investors Undervaluing Henry Schein, Inc. (NASDAQ:HSIC) By 48%?
Morgan Stanley Maintains Henry Schein(HSIC.US) With Sell Rating, Maintains Target Price $55
Morgan Stanley Keeps Their Sell Rating on Henry Schein (HSIC)
Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC) and CSL (OtherCMXHF)
Here's What's Concerning About Henry Schein's (NASDAQ:HSIC) Returns On Capital
Henry Schein Sets Science-Based Emissions Reduction Targets for 2030 and 2050
IntelePeer Joins Henry Schein One API Exchange as an Authorized Integration Vendor
Fluoride Ban in Water Bill Signed by Utah Governor
Why Is Henry Schein (HSIC) Down 3.9% Since Last Earnings Report?
Is The Market Rewarding Henry Schein, Inc. (NASDAQ:HSIC) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
Express News | Henry Schein Inc : Jefferies Cuts Target Price to $78 From $87
Mizuho Securities Maintains Henry Schein(HSIC.US) With Hold Rating, Announces Target Price $76
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
Henry Schein Will Showcase a Selection of the Company's Comprehensive Solutions for Oral Health Professionals at the 2025 International Dental Show
Mizuho Adjusts Price Target on Henry Schein to $76 From $78, Maintains Neutral Rating
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
Major Henry Schein Stock Sales by Top Executives!
Insider Sale: Director at $HSIC Sells 2,604 Shares
Express News | FOMC Projects Lower GDP and Uncertainty, No Rate Change